Microsoft is joining forces with Harvard Medical School to enhance its Copilot AI assistant with verified medical information from Harvard Health Publishing, according to a report by The Wall Street Journal. The partnership is part of Microsoft’s broader strategy to reduce its heavy reliance on OpenAI, the developer behind ChatGPT, and diversify its artificial intelligence ecosystem.
The upgraded Copilot, expected to launch as early as this month, will provide users with more accurate and reliable healthcare answers. By integrating Harvard Health’s content, Copilot aims to deliver medical insights comparable to professional advice, offering users credible information directly through Microsoft’s productivity tools such as Word, Outlook, and Windows. Microsoft will reportedly pay Harvard a licensing fee to access and utilize this health data.
Dominic King, vice president of health at Microsoft AI, told the Journal that the company’s mission is to ensure Copilot delivers responses aligned with what users might hear from a healthcare practitioner, improving accuracy and trust in AI-generated medical information.
While Harvard has yet to comment on the partnership, Microsoft declined to provide further details beyond the report. This collaboration reflects Microsoft’s ongoing effort to strengthen its AI offerings beyond OpenAI’s technology. In addition to using OpenAI’s models, Microsoft has started integrating Anthropic’s Claude AI and is developing its own in-house models to build a more independent and diverse AI infrastructure.
By combining trusted medical expertise with advanced AI capabilities, Microsoft’s Copilot update could set a new standard for AI-driven health information, emphasizing credibility, safety, and innovation in digital healthcare.


CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Jeff Bezos Eyes $100 Billion Fund to Transform Manufacturing With AI
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
Palantir's Maven AI Earns Pentagon "Program of Record" Status, Reshaping Military AI Strategy
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 



